Márcia Gonçalves Ribeiro

Márcia Gonçalves Ribeiro

Auto-generated profile, based on publicly available information

Márcia Gonçalves Ribeiro

Universidade Federal do Rio de Janeiro, Brazil

Research Focus & Metrics

Academic Career Length

26Years (2001-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 November 2010 in Genetics and Molecular Biology
Verified
Journal Article
Open access
PDF file
RGRoberto Giugliani
Roberto Giugliani
AFAndressa Federhen
Andressa Federhen
MRMaria Verônica Muñoz Rojas
Maria Verônica Muñoz Rojas
TVTaiane Vieira
Taiane Vieira
OAOsvaldo Artigalás
Osvaldo Artigalás
AMAna Maria Martins
Ana Maria Martins
Mucopolysaccharidoses (MPS) are rare genetic diseases caused by the deficiency of one of the lysosomal enzymes involved in the glycosaminoglycan (GAG) breakdown pathway. This metabolic block leads to the accumulation of GAG in various organs and tissues of the affected patients, resulting in a multisystemic clinical picture, sometimes including cognitive impairment. Until the beginning of the XXI century, treatment was mainly supportive. Bone marrow transplantation improved the natural course of the disease in some types of MPS, but the morbidity and mortality restricted its use to selected cases. The identification of the genes involved, the new molecular biology tools and the availability of animal models made it possible to develop specific enzyme replacement therapies (ERT) for these diseases. At present, a great number of Brazilian medical centers from all regions of the country have experience with ERT for MPS I, II, and VI, acquired not only through patient treatment but also in clinical trials. Taking the three types of MPS together, over 200 patients have been treated with ERT in our country. This document summarizes the experience of the professionals involved, along with the data available in the international literature, bringing together and harmonizing the information available on the management of these severe and progressive diseases, thus disclosing new prospects for Brazilian patients affected by these conditions.

23 March 2007 in Acta Paediatrica
Verified
Journal Article
Closed access
PDF file
ISIda V.D. Schwartz
Ida V.D. Schwartz
MRMárcia G Ribeiro
Márcia G Ribeiro
JMJoão G Mota
João G Mota
MTMaria Betânia P Toralles
Maria Betânia P Toralles
PCPatrícia Correia
Patrícia Correia
RGRoberto Giugliani
Roberto Giugliani

25 June 2004 in Clinical Genetics
Verified
Journal Article
Closed access
PDF file
AAAcmm Azevedo
Acmm Azevedo
ISIv Schwartz
Iv Schwartz
LKL Kalakun
L Kalakun
SBS Brustolin
S Brustolin
MBMg Burin
Mg Burin
RGR Giugliani
R Giugliani

10 June 2008 in American Journal of Medical Genetics Part A
Verified
Journal Article
Closed access
PDF file
TVTaiane Vieira
Taiane Vieira
ISIda V.D. Schwartz
Ida V.D. Schwartz
VMVerónica Muñoz
Verónica Muñoz
LPLouise Pinto
Louise Pinto
CSCarlos Steiner
Carlos Steiner
RGRoberto Giugliani
Roberto Giugliani

1 July 2011 in Neuroscience Letters
Verified
Journal Article
Closed access
CRCíntia Rebouças
Cíntia Rebouças
NFNatalia Fintelman-Rodrigues
Natalia Fintelman-Rodrigues
LJLars R. Jensen
Lars R. Jensen
AKAndreas W. Kuss
Andreas W. Kuss
MRMárcia G. Ribeiro
Márcia G. Ribeiro
MPMárcia M.G. Pimentel
Márcia M.G. Pimentel

17 June 2005 in BMC Endocrine Disorders
Verified
Journal Article
Open access
PDF file
CFCristina T Fonseca
Cristina T Fonseca
DADaniela M Amaral
Daniela M Amaral
MRMárcia G Ribeiro
Márcia G Ribeiro
IBIzabel Cr Beserra
Izabel Cr Beserra
MGMarília M Guimarães
Marília M Guimarães
Background: The prevalence of diabetes mellitus is higher in individuals with Down syndrome (DS) than in the general population; it may be due to the high prevalence of obesity presented by many of them. The aim of this study was to evaluate the insulin resistance (IR) using the HOMA (Homeostasis Model Assessment) method, in DS adolescents, describing it according to the sex, body mass index (BMI) and pubertal development. Methods: 15 adolescents with DS (8 males and 7 females) were studied, aged 10 to 18 years, without history of disease or use of medication that could change the suggested laboratory evaluation. On physical examination, the pubertal signs, acanthosis nigricans (AN), weight and height were evaluated. Fasting plasma glucose and insulin were analysed by the colorimetric method and RIA-kit LINCO, respectively. IR was calculated using the HOMA method. The patients were grouped into obese, overweight and normal, according to their BMI percentiles. The EPIINFO 2004 software was used to calculate the BMI, its percentile and Z score. Results: Five patients were adults (Tanner V or presence of menarche), 9 pubertal (Tanner II – IV) and 1 prepubertal (Tanner I). No one had AN. Two were obese, 4 overweight and 9 normal. Considering the total number of patients, HOMA was 1.7 ± 1.0, insulin 9.3 ± 4.8 μU/ml and glucose 74.4 ± 14.8 mg/dl. The HOMA values were 2.0 ± 1.0 in females and 1.5 ± 1.0 in males. Considering the nutritional classification, the values of HOMA and insulin were: HOMA: 3.3 ± 0.6, 2.0 ± 1.1 and 1.3 ± 0.6, and insulin: 18.15 ± 1.6 μU/ml, 10.3 ± 3.5 μU/ml and 6.8 ± 2.8 μU/ml, in the obese, overweight and normal groups respectively. Considering puberty, the values of HOMA and insulin were: HOMA: 2.5 ± 1.3, 1.4 ± 0.6 and 0.8 ± 0.0, and insulin: 13.0 ± 5.8 μU/ml, 7.8 ± 2.9 μU/ml and 4.0 ± 0.0 μU/ml, in the adult, pubertal and prepubertal groups respectively. Conclusion: The obese and overweight, female and adult patients showed the highest values of HOMA and insulin.